Acuta Capital Partners’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-863,100
| Closed | -$18.5M | – | 53 |
|
|
2020
Q4 | $18.5M | Buy |
863,100
+33,100
| +4% | +$709K | 5.03% | 4 |
|
|
2020
Q3 | $12.6M | Buy |
830,000
+6,831
| +0.8% | +$104K | 3.42% | 6 |
|
|
2020
Q2 | $10.3M | Buy |
823,169
+707,669
| +613% | +$8.83M | 2.97% | 11 |
|
|
2020
Q1 | $1.07M | Buy |
115,500
+32,167
| +39% | +$297K | 0.52% | 29 |
|
|
2019
Q4 | $1.11M | Buy |
+83,333
| New | +$1.11M | 0.27% | 34 |
|
|
2018
Q3 | – | Sell |
-20,833
| Closed | -$2.56M | – | 33 |
|
|
2018
Q2 | $2.56M | Buy |
+20,833
| New | +$2.56M | 0.46% | 28 |
|
|
2015
Q4 | – | Sell |
-4,293
| Closed | -$1.65M | – | 57 |
|
|
2015
Q3 | $1.65M | Sell |
4,293
-115
| -3% | -$44.1K | 0.95% | 33 |
|
|
2015
Q2 | $1.83M | Sell |
4,408
-3,925
| -47% | -$1.63M | 1.13% | 26 |
|
|
2015
Q1 | $3.96M | Sell |
8,333
-22
| -0.3% | -$10.5K | 3.34% | 8 |
|
|
2014
Q4 | $3.09M | Buy |
+8,355
| New | +$3.09M | 2.09% | 7 |
|